AdvisorShares Psychedelics ETF Rating

$1.29
+0.01 (+0.78%)
(As of 05/3/2024 ET)

AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

PSIL Aggregate Rating

Moderate Buy
2.88

Holdings in PSIL have an aggregate rating of Moderate Buy based on 62 analyst ratings issued in the past year covering 11 companies (58.9% of the portfolio).

PSIL Aggregate Price Target

$15.87
1,129.94% Upside
High Prediction$28.80
Average Prediction$15.87
Low Prediction$7.58

Holdings in PSIL have an aggregate price target of $15.87 and a range of $7.58 to $28.80 covering 11 companies (58.9% of the portfolio).

PSIL Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
Moderate Buy
2 Moderate Buy rating(s)
Hold
2 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by AdvisorShares Psychedelics ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 11 PSIL Holdings

Weight
In ETF
CompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
14.76%
Mind Medicine (MindMed) Inc.d stock logo
MNMD
Mind Medicine (MindMed)
$10.00
+5.0%
2 of 5 stars
3.00$25.20 152.0%6Upcoming Earnings
6.93%
COMPASS Pathways plcd stock logo
CMPS
COMPASS Pathways
$8.53
+3.4%
1 of 5 stars
3.00$47.40 455.7%5Upcoming Earnings
Analyst Report
Short Interest ↑
News Coverage
5.43%
Atai Life Sciencesd stock logo
ATAI
Atai Life Sciences
$2.05
-3.8%
2 of 5 stars
3.00$10.50 412.2%3Upcoming Earnings
Short Interest ↑
5.42%
Vistagen Therapeutics, Inc.d stock logo
VTGN
Vistagen Therapeutics
$4.50
+2.0%
1 of 5 stars
3.00$19.00 322.2%4Positive News
5.32%
GH Research PLCd stock logo
GHRS
GH Research
$11.68
+4.4%
2 of 5 stars
3.00$39.50 238.2%2Upcoming Earnings
News Coverage
5.28%
Intra-Cellular Therapies, Inc.d stock logo
ITCI
Intra-Cellular Therapies
$68.80
-2.2%
5 of 5 stars
2.90$90.17 31.1%10Upcoming Earnings
4.73%
Alkermes plcd stock logo
ALKS
Alkermes
$24.05
+0.8%
5 of 5 stars
2.50$35.38 47.1%10Earnings Report
Analyst Report
Short Interest ↓
Analyst Revision
News Coverage
3.78%
Enveric Biosciences, Inc.d stock logo
ENVB
Enveric Biosciences
$0.98
+5.4%
2 of 5 stars
3.00$10.00 920.4%1News Coverage
Gap Down
3.15%
Sage Therapeutics, Inc.d stock logo
SAGE
Sage Therapeutics
$13.94
+6.3%
4 of 5 stars
2.12$37.67 170.2%17Analyst Report
Gap Up
2.51%
Seelos Therapeutics, Inc.d stock logo
SEEL
Seelos Therapeutics
$0.34
+3.0%
2 of 5 stars
2.33$70.00 20,530.7%3News Coverage
Gap Up
1.62%
Lucy Scientific Discovery Inc.d stock logo
LSDI
Lucy Scientific Discovery
$0.82
+1.2%
0 of 5 stars
3.001Upcoming Earnings
News Coverage
Positive News
This page (NYSEARCA:PSIL) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners